Tyrosine Kinase Inhibitor Dosing Patterns in Elderly Patients With Chronic Myeloid Leukemia-Reference-Cited by-同舟云学术

Tyrosine Kinase Inhibitor Dosing Patterns in Elderly Patients With Chronic Myeloid Leukemia

Published:2019-11 Issue:11 Volume:19 Page:735-743.e2
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Seo Hee Yeon,Ko Tae Hwa,Hyun Shin Young,Song Hyebin,Lim Seung Taek,Shim Kwang Yong,Lee Jong In,Kong Jee Hyun

Funder

Yonsei University Wonju College of Medicine

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference41 articles.

1. Prognostic discrimination in “good-risk” chronic granulocytic leukemia;Sokal;Blood,1984

2. A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Writing Committee for the Collaborative CML Prognostic Factors Project Group;Hasford;J Natl Cancer Inst,1998

3. Life expectancy of patients with chronic myeloid leukemia approaches the life expectancy of the general population;Bower;J Clin Oncol,2016

4. The Hasford score may predict molecular response in chronic myeloid leukemia patients: a single institution experience;Dybko;Dis Markers,2016

5. Comparison of the utility and applicability of the Sokal, Hasford, and EUTOS scores in a population of Chinese patients with chronic-phase chronic myeloid leukemia undergoing imatinib therapy;Xia;Onco Targets Ther,2015

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and Efficacy of TKIs in very Elderly Patients (≥75 Years) with Chronic Myeloid Leukemia;Journal of Clinical Medicine;2024-01-03

2. Real-world Management of CML: Outcomes and Treatment Patterns;Current Hematologic Malignancy Reports;2023-07-03

3. Computational identification of host genomic biomarkers highlighting their functions, pathways and regulators that influence SARS-CoV-2 infections and drug repurposing;Scientific Reports;2022-03-11

4. Potential to Improve Therapy of Chronic Myeloid Leukemia (CML), Especially for Patients with Older Age: Incidence, Mortality, and Survival Rates of Patients with CML in Switzerland from 1995 to 2017;Cancers;2021-12-14

5. Efficacy and Safety of Imatinib Treatment in Elderly Patients With Chronic Myeloid Leukemia: Real-Life Data and a Single-Center Experience;Clinical Lymphoma Myeloma and Leukemia;2021-08